Effects of Ranolazine on Astrocytes and Neurons in Primary Culture

Abstract

Ranolazine (Rn) is an antianginal agent used for the treatment of chronic angina pectoris when angina is not adequately controlled by other drugs. Rn also acts in the central nervous system and it has been proposed for the treatment of pain and epileptic disorders. Under the hypothesis that ranolazine could act as a neuroprotective drug, we studied its effects on astrocytes and neurons in primary culture. We incubated rat astrocytes and neurons in primary cultures for 24 hours with Rn (10−7, 10−6 and 10−5 M). Cell viability and proliferation were measured using trypan blue exclusion assay, MTT conversion assay and LDH release assay. Apoptosis was determined by Caspase 3 activity assay. The effects of Rn on pro-inflammatory mediators IL-β and TNF-α was determined by ELISA technique, and protein expression levels of Smac/Diablo, PPAR-γ, Mn-SOD and Cu/Zn-SOD by western blot technique. In cultured astrocytes, Rn significantly increased cell viability and proliferation at any concentration tested, and decreased LDH leakage, Smac/Diablo expression and Caspase 3 activity indicating less cell death. Rn also increased anti-inflammatory PPAR-γ protein expression and reduced pro-inflammatory proteins IL-1 β and TNFα levels. Furthermore, antioxidant proteins Cu/Zn-SOD and Mn-SOD significantly increased after Rn addition in cultured astrocytes. Conversely, Rn did not exert any effect on cultured neurons. In conclusion, Rn could act as a neuroprotective drug in the central nervous system by promoting astrocyte viability, preventing necrosis and apoptosis, inhibiting inflammatory phenomena and inducing anti-inflammatory and antioxidant agents.

Sulbactam Protects Hippocampal Neurons Against Oxygen-Glucose Deprivation by Up-Regulating Astrocytic GLT-1 via p38 MAPK Signal Pathway

“…MTT can detect the activity of succinate dehydrogenase in mitochondria and then to be used to measure cell viability. The assay was conducted as previously described (Aldasoro et al, 2016 ). The co-cultures of neuron-astrocytes in 24-well plate were incubated with MTT (0.5 mg ml −1 in final concentration; Sigma-Aldrich China Inc., China) for 4 h at 37°C.…”

Metabolic and Cognitive Effects of Ranolazine in Type 2 Diabetes Mellitus: Data from an in vivo Model

“…In a study carried out on primary cultures of astrocytes and neurons, incubated for 24 h with ranolazine, the treatment increased cell viability and proliferation. Ranolazine also increased anti-inflammatory PPAR-γ protein expression and reduced pro-inflammatory proteins, interleukin-1 β, and Tumor Necrosis Factor-α, levels [15]. Therefore, it is possible to hypothesize that ranolazine could act as a neuroprotective drug in the CNS by promoting astrocyte viability and preventing necrosis and apoptosis.…”

Glycolysis and Fatty Acid Oxidation Inhibition Improves Survival in Glioblastoma

“…In a syngeneic glioma model (oncogenic neural stem cells), etomoxir increased survival ( 10 ), whereas, the combination of etomoxir, glucose analog, and glycolytic inhibitor 2-deoxy-D-glucose (2-DG) led to metabolic lethality in vitro and increased median survival in MES93 mesenchymal GBM tumor-bearing mice ( 11 ). Ranolazine (Rano), a partial FAO inhibitor, has shown neuroprotective effects on healthy astrocytes and neurons in rodent cell cultures ( 12 ). Targeting FAO in GBM also shows promise in alleviating the immunosuppressive tumor microenvironment as FAO ameliorates the tolerogenic and immunosuppressive mechanisms of tumor myeloid-derived suppressor cells (MDSC) and reduces tumor growth in the syngeneic murine models of lung (3LL) and colon (MCA-38) cancer ( 13 ).…”